These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6871919

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardiovascular effects of aprindine, a new antiarrhythmic drug.
    Remme WJ, Verdouw PD.
    Eur J Cardiol; 1975 Dec; 3(4):307-13. PubMed ID: 1193115
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical effects and plasma concentration levels of aprindine hydrochloride in patients with tachyarrhythmias].
    Kasahara S, Shibata N, Mizobe H, Shoda M, Miyazaki Y, Miura M, Miyazawa Y, Komatsu Y.
    Kokyu To Junkan; 1989 Nov; 37(11):1225-30. PubMed ID: 2602679
    [Abstract] [Full Text] [Related]

  • 8. Effective plasma concentrations of aprindine in canine ventricular arrhythmias.
    Hashimoto K, Komori S, Ishii M, Kamiya J.
    J Cardiovasc Pharmacol; 1984 Nov; 6(1):12-9. PubMed ID: 6199593
    [Abstract] [Full Text] [Related]

  • 9. Aprindine for treatment of ventricular arrhythmias in the dog.
    Muir WW, Bonagura JD.
    Am J Vet Res; 1982 Oct; 43(10):1815-9. PubMed ID: 7149383
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiarrhythmic and antifibrillatory properties of aprindine.
    Kroll DA, Lucchesi BR.
    J Pharmacol Exp Ther; 1975 Aug; 194(2):427-34. PubMed ID: 1151768
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of patients receiving aprindine. Safety and efficacy.
    Strasberg B, Prechel D, Bauman J, Coelho A, Swiryn S, Bauernfeind R, Rosen KM.
    Arch Intern Med; 1983 Nov; 143(11):2131-3. PubMed ID: 6639232
    [Abstract] [Full Text] [Related]

  • 13. [Detection of aprindine and its metabolites in plasma and urine].
    Wirth KE, Breithardt G, Michaelis L.
    Herz; 1983 Oct; 8(5):302-8. PubMed ID: 6642401
    [Abstract] [Full Text] [Related]

  • 14. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D, Napoli V, Passantino A, Ricci A, Lagioia R, Rizzon P.
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [Abstract] [Full Text] [Related]

  • 15. [Changes in hemodynamics and contractility during supraventricular tachycardias and after electrical or aprindin-induced termination (author's transl)].
    Weppner HG, Merle H, Schlepper M.
    Arzneimittelforschung; 1976 Jun; 26(12):2205-8. PubMed ID: 1037277
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A, Gryczynska M, Ziemnicka K, Czepczynski R, Sowinski J, Wysocki H.
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [Abstract] [Full Text] [Related]

  • 19. Effects on rabbit cardiac potentials of aprindine and indecainide, a new antiarrhythmic agent, in normoxia and hypoxia.
    Dennis PD, Vaughan Williams EM.
    Br J Pharmacol; 1985 May; 85(1):11-9. PubMed ID: 4027460
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.